Cargando…
Neo-Splicetopes in Tumor Therapy: A Lost Case?
Proteasome generates spliced peptides by ligating two distant cleavage products in a reverse proteolysis reaction. The observation that CD8+ T cells recognizing a spliced peptide induced T cell rejection in a melanoma patient following adoptive T cell transfer (ATT), raised some hopes with regard to...
Autor principal: | Kloetzel, Peter M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8898901/ https://www.ncbi.nlm.nih.gov/pubmed/35265089 http://dx.doi.org/10.3389/fimmu.2022.849863 |
Ejemplares similares
-
In vitro proteasome processing of neo-splicetopes does not predict their presentation in vivo
por: Willimsky, Gerald, et al.
Publicado: (2021) -
HLA-G Neo-Expression on Tumors
por: Loustau, Maria, et al.
Publicado: (2020) -
Editorial: Immunopeptidomic Approaches for the Identification of Tumor (neo)Antigens
por: Lill, Jennie R., et al.
Publicado: (2022) -
Tissue-resident memory T cells in the era of (Neo) adjuvant melanoma management
por: Plunkett, Kai R., et al.
Publicado: (2022) -
Thymus antibody-secreting cells: once forgotten but not lost
por: Pioli, KimAnh Trang, et al.
Publicado: (2023)